Showing results (1611-1620 of 1,672) with videos related to

Sort By:
Pageof 168
Therapeutic Advances in Medical Oncology|February 13, 2025
Association of baseline inflammatory biomarkers and clinical outcomes in patients with advanced renal cell carcinoma treated with immune checkpoint inhibitorsAhmet Yildirim, Mengting Wei, Yuan Liu, et al.
Blood|August 30, 2002
A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemiasOliver G Ottmann, Brian J Druker, Charles L Sawyers, et al.
Journal of Immunotherapy and Precision Oncology|August 29, 2022
Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University ExperienceDylan J Martini, T Anders Olsen, Subir Goyal, et al.
Leukemia|August 17, 2011
KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinibD Marin, I H Gabriel, S Ahmad, et al.
Msystems|November 9, 2016
ASM Journals Eliminate Impact Factor Information from Journal WebsitesArturo Casadevall, Stefano Bertuzzi, Michael J Buchmeier, et al.
Leukemia|November 20, 2009
Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA allelesB E Shaw, N P Mayor, N H Russell, et al.
Frontiers in Oncology|July 5, 2021
Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint BlockadeT Anders Olsen, Dylan J Martini, Subir Goyal, et al.
Scientific Reports|December 1, 2023
Exploring relationships among multi-disciplinary assessments for knee joint health in service members with traumatic unilateral lower limb loss: a two-year longitudinal investigationJoseph G Wasser, Brad D Hendershot, Julian C Acasio, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 22, 2003
Clinical characteristics of 13 solid organ transplant recipients with ganciclovir-resistant cytomegalovirus infectionC M Isada, B Yen-Lieberman, N S Lurain, et al.
Frontiers in Oncology|July 26, 2021
Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint InhibitorsDylan J Martini, T Anders Olsen, Subir Goyal, et al.
Pageof 168